Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Spotify (SPOT) : "Let's take a long-term view. This stock is a buy."
Sorrento Therapeutics (SRNE) : "This is the kind of speculative stock that I like."
Kohlberg Kravis Roberts (KKR) : "I'm a buyer. I've respected them for generations. "
Sage Therapeutics (SAGE) : "Let's wait and see. I can't bless it until I see more from them."
Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer says if you're sitting on a down-and-out stock with a real bad chart, you need to hold on at this point because an analyst or a quarter could come to your rescue. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.